inTEST executive forfeits 2,076 restricted shares

INTEST CORP Division President–Electronic Test Joseph Richard McManus Jr. reported a disposition of 2,076 shares of common stock on March 4, 2026, recorded as a “Disposition to issuer” at a price of $0.00 per share.

Rhea-AI Filing Summary

INTEST CORP Division President–Electronic Test Joseph Richard McManus Jr. reported a disposition of 2,076 shares of common stock on March 4, 2026, recorded as a “Disposition to issuer” at a price of $0.00 per share. A footnote explains these shares were forfeited under the terms of his performance-based restricted stock award granted on March 8, 2023. After this forfeiture, he directly holds 31,252 common shares. The filing also updates his employee stock option positions, showing several option grants that vest in four equal annual installments beginning on March 17, 2026, March 6, 2025, March 8, 2024, and April 28, 2023, plus one option grant that is fully vested as of the report date.

Insider Trade Summary

Disposition: 2,076 shares

Disposition 7 txns

Insider McManus Joseph Richard Jr.

Role Division Pres-Electronic Test

Type	Security	Shares	Price	Value
Disposition	Common Stock	2,076	$0.00	$0.00
holding	Employee Stock Option (right to buy)	--	--	--
holding	Employee Stock Option (right to buy)	--	--	--
holding	Employee Stock Option (right to buy)	--	--	--
holding	Employee Stock Option (right to buy)	--	--	--
holding	Employee Stock Option (right to buy)	--	--	--
holding	Employee Stock Option (right to buy)	--	--	--

Holdings After Transaction: Common Stock — 31,252 shares (Direct); Employee Stock Option (right to buy) — 43,016 contracts (Direct)

Footnotes (7)

1. F1. Shares forfeited under the terms of Mr. McManus's performance-based restricted stock award granted on March 8, 2023.
2. F2. This option vests in four equal annual installments commencing on March 17, 2026.
3. F3. This option vests in four equal annual installments commencing on March 17, 2026.
4. F4. This option vests in four equal annual installments commencing on March 6, 2025.
5. F5. This option vests in four equal annual installments commencing on March 8, 2024.
6. F6. This option vests in four equal annual installments commencing on April 28, 2023.
7. F7. This option is fully vested as of the date of this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did INTT executive Joseph McManus report?

Joseph Richard McManus Jr. reported forfeiting 2,076 shares of INTT common stock back to the company. The disposition occurred on March 4, 2026 at a stated price of $0.00 per share under his performance-based restricted stock award.

Why were 2,076 INTT shares forfeited by Joseph McManus?

The 2,076 INTT shares were forfeited under the terms of McManus’s performance-based restricted stock award granted on March 8, 2023. Performance-based awards typically cancel or reduce if pre-set performance conditions are not fully satisfied.

How many INTT common shares does Joseph McManus own after this Form 4?

After the reported forfeiture, McManus directly owns 31,252 shares of INTT common stock. This figure reflects his holdings following the March 4, 2026 disposition to the issuer of 2,076 shares from his performance-based restricted stock award.

What stock options are reported for INTT executive Joseph McManus?

The filing lists multiple employee stock options for McManus, each a right to buy INTT shares. Several grants vest in four equal annual installments starting March 17, 2026, March 6, 2025, March 8, 2024, and April 28, 2023, with one option already fully vested.

Is the 2,076-share INTT disposition a sale on the open market?

No, the 2,076-share transaction is labeled as a “Disposition to issuer” at $0.00 per share and is described as a forfeiture under McManus’s performance-based restricted stock award, rather than an open-market sale of INTT shares.

What role does Joseph McManus hold at INTT in this Form 4?

In this Form 4, Joseph Richard McManus Jr. is identified as an officer of INTT with the title Division President–Electronic Test. The filing covers his direct holdings of common stock and his employee stock option awards in that capacity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McManus Joseph Richard Jr.

(Last) (First) (Middle)

C/O INTEST CORP

804 EAST GATE DR, SUITE 200

(Street)

MT. LAUREL NJ 08054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTEST CORP [ INTT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Division Pres-Electronic Test

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		D		2,076(1)	D	$0	31,252	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$7.74							(2)	03/16/2035	Common Stock	2,006		2,006	D
Employee Stock Option (right to buy)	$7.74							(3)	03/16/2035	Common Stock	7,954		7,954	D
Employee Stock Option (right to buy)	$11.33							(4)	03/05/2034	Common Stock	5,600		5,600	D
Employee Stock Option (right to buy)	$16.06							(5)	03/07/2033	Common Stock	3,576		3,576	D
Employee Stock Option (right to buy)	$8.14							(6)	04/27/2032	Common Stock	13,880		13,880	D
Employee Stock Option (right to buy)	$13.13							(7)	04/27/2031	Common Stock	10,000		10,000	D

Explanation of Responses:

1. Shares forfeited under the terms of Mr. McManus's performance-based restricted stock award granted on March 8, 2023.

2. This option vests in four equal annual installments commencing on March 17, 2026.

3. This option vests in four equal annual installments commencing on March 17, 2026.

4. This option vests in four equal annual installments commencing on March 6, 2025.

5. This option vests in four equal annual installments commencing on March 8, 2024.

6. This option vests in four equal annual installments commencing on April 28, 2023.

7. This option is fully vested as of the date of this report.

	/s/ Joseph McManus, Jr.	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.